Heba A. Abd El Razik

Author

Alexandria University ORCID

Also Known As

Heba A Abd El Razik, Heba A. Abd El Razik, Heba A. Razik, Heba Attia Abd El Razik

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Alexandria University City of Scientific Research and Technological Applications King Abdulaziz University Pharos University in Alexandria GTx (United States)

About

Heba A. Abd El Razik is an author at Alexandria University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	833
2	Pharmacology	11	11	833
3	Natural Sciences	3	3	80
4	Biochemistry	3	3	80
5	Biomolecular Engineering	3	3	305

Heba A. Abd El Razik

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents Sherif A. F. Rostom, Ibrahim M. El‐Ashmawy, Heba A. Abd El Razik, Bioorganic & Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)Potential Non-acidic Anti-inflammatoryMedicinePharmacological Agent	2008	215
New heterocyclic hybrids of pyrazole and its bioisosteres: Design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents Adnan A. Bekhit, Ahmed M. Hassan, Heba A. Abd El Razik, European Journal of Medicinal Chemistry Antifungal AgentAntiparasitic AgentMedicineDrug DiscoveryDiversity-oriented Synthesis	2015	155
Azole antimicrobial pharmacophore-based tetrazoles: Synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents Sherif A. F. Rostom, Hayam M. A. Ashour, Heba A. Abd El Razik, Bioorganic & Medicinal Chemistry Anticonvulsant AgentsAntiparasitic AgentPotential AntimicrobialMedicinePharmacotherapy	2009	133
Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential Ola S Afifi, Omaima G. Shaaban, Heba A. Abd El Razik, Bioorganic Chemistry Medicinal ChemistryMedicineDrug Discovery15-Lox InhibitorsPharmacotherapy	2019	82
Synthesis and Biological Evaluation of Some Novel Polysubstituted Pyrimidine Derivatives as Potential Antimicrobial and Anticancer Agents Sherif A. F. Rostom, Hayam M. A. Ashour, Heba A. Abd El Razik Archiv der Pharmazie	2009	79
Synthesis of Some Pyrazolines and Pyrimidines Derived from Polymethoxy Chalcones as Anticancer and Antimicrobial Agents Sherif A. F. Rostom, M. Badr, Heba A. Abd El Razik, Archiv der Pharmazie	2011	71
Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies Mai S. El-Shoukrofy, Heba A. Abd El Razik, Omaima M. Aboulwafa, Bioorganic Chemistry Vivo Anti-inflammatory ActivityMedicinal ChemistryMedicineDrug DiscoverySilico Chemo-informatic Studies	2019	68
A Novel COX‐2 Inhibitor Pyrazole Derivative Proven Effective as an Anti‐Inflammatory and Analgesic Drug Mahmoud M. Mohy El‐Din, Amira Senbel, Azza A. Bistawroos, Basic & Clinical Pharmacology & Toxicology Medicinal ChemistryAnti-inflammatoryPharmacological StudyPain MedicinePharmacology	2010	54
Benzodioxole–Pyrazole Hybrids as Anti‐Inflammatory and Analgesic Agents with COX‐1,2/5‐LOX Inhibition and Antioxidant Potential Heba A. Abd El Razik, M. Badr, Attia H. Atta, Archiv der Pharmazie	2017	54
Synthesis and Biological Evaluation of Some Novel Fused Pyrazolopyrimidines as Potential Anticancer and Antimicrobial Agents Heba A. Abd El Razik, Abeer E. Abdel Wahab Archiv der Pharmazie Antimicrobial ChemotherapyPharmaceutical ChemistryNovel PyrazolopyrimidinesPotential AnticancerDrug Resistance	2010	29

Page 1